Monsanto Company (NYSE:MON) VP Nicole M. Ringenberg sold 7,890 shares of the business’s stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $122.25, for a total value of $964,552.50. Following the sale, the vice president now owns 38,600 shares of the company’s stock, valued at $4,718,850. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Monsanto Company (NYSE MON) opened at 121.52 on Friday. The firm has a market capitalization of $53.41 billion, a PE ratio of 23.88 and a beta of 1.07. The company has a 50-day moving average price of $119.82 and a 200-day moving average price of $117.73. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $122.80.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. The firm had revenue of $2.69 billion during the quarter, compared to analysts’ expectations of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. Monsanto’s revenue for the quarter was up 4.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.07 EPS. On average, analysts predict that Monsanto Company will post $5.70 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, October 6th were paid a $0.54 dividend. The ex-dividend date of this dividend was Thursday, October 5th. This represents a $2.16 annualized dividend and a yield of 1.78%. Monsanto’s payout ratio is currently 42.27%.
COPYRIGHT VIOLATION NOTICE: “Insider Selling: Monsanto Company (NYSE:MON) VP Sells 7,890 Shares of Stock” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another publication, it was illegally copied and republished in violation of US & international trademark & copyright law. The original version of this story can be read at https://www.dispatchtribunal.com/2017/10/28/monsanto-company-mon-vp-nicole-m-ringenberg-sells-7890-shares-of-stock.html.
A number of hedge funds have recently added to or reduced their stakes in the business. Intact Investment Management Inc. purchased a new stake in shares of Monsanto during the 3rd quarter valued at $239,000. Crossmark Global Holdings Inc. purchased a new stake in shares of Monsanto during the 3rd quarter valued at $3,409,000. Parkside Financial Bank & Trust grew its stake in shares of Monsanto by 10.2% during the 3rd quarter. Parkside Financial Bank & Trust now owns 4,865 shares of the basic materials company’s stock valued at $583,000 after buying an additional 452 shares during the period. Athos Capital Ltd grew its stake in shares of Monsanto by 469.1% during the 3rd quarter. Athos Capital Ltd now owns 142,286 shares of the basic materials company’s stock valued at $16,091,000 after buying an additional 117,286 shares during the period. Finally, Callahan Advisors LLC grew its stake in shares of Monsanto by 9.8% during the 3rd quarter. Callahan Advisors LLC now owns 60,023 shares of the basic materials company’s stock valued at $7,192,000 after buying an additional 5,335 shares during the period. 74.67% of the stock is owned by hedge funds and other institutional investors.
Several equities research analysts have commented on the company. BMO Capital Markets reiterated a “buy” rating and set a $128.00 price objective on shares of Monsanto in a research note on Thursday, October 5th. Barclays PLC reiterated an “equal weight” rating and set a $124.00 price objective (up from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. Macquarie lowered Monsanto from an “outperform” rating to a “neutral” rating in a research note on Wednesday, October 4th. Wells Fargo & Company upped their price target on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research report on Tuesday, October 10th. Finally, Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a research report on Tuesday, July 4th. Eleven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Monsanto currently has an average rating of “Hold” and an average target price of $124.61.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.